A a single-institution retrospective study analysing Lifitegrast for treatment of ocular chronic graft-versus-host disease
Latest Information Update: 17 May 2021
Price :
$35 *
At a glance
- Drugs Lifitegrast (Primary)
- Indications Keratoconjunctivitis
- Focus Adverse reactions; Therapeutic Use
- 17 May 2021 New trial record